Daily non-political popular news in brief.

International AIDS Vaccine Initiative (IAVI) statement on male circumcision

The International AIDS Vaccine Initiative (IAVI) issued this statement today following a National Institutes of Health (NIH) decision to end two clinical trials of adult male circumcision in Uganda and Kenya. The NIH's Data Safety and Monitoring Board (DSMB), reviewing interim data, found that medically performed circumcision significantly protected men in the trial from HIV infection.

Read more »

Keywords: international, aids, vaccine, initiative, iavi, statement, male, circumcision, aid

« Previous | Next »

Similar news on "International AIDS Vaccine Initiative (IAVI) statement on male circumcision":

1. IAVI statement on new analysis of STEP large-scale AIDS vaccine trial
   11-07-2007 · EurekAlert!
   The International AIDS Vaccine Initiative issued the following statement from its president and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study.
   Similar news · Read more »
   
2. 30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
   01-31-2007 · EurekAlert!
   The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006. There are now more than 30 trials ongoing in 24 countries, across every continent.
   Similar news · Read more »
   
3. Male circumcision overstated as prevention tool against AIDS
   06-20-2007 · EurekAlert!
   In new academic research published today in the online, open-access, peer-reviewed scientific journal PLoS ONE, male circumcision is found to be much less important as a deterrent to the global AIDS pandemic than previously thought. The author, John R. Talbott, has conducted statistical empirical research across 77 countries of the world and has uncovered some surprising results.
   Similar news · Read more »
   
4. IAVI, CDC and USMHRP release new data redefining laboratory reference ranges in Africa
   08-21-2007 · EurekAlert!
   Leading researchers from IAVI, CDC and the USMHRP presented final results today from a collection of independent studies re-examining the medical criteria for including African volunteers in AIDS vaccine trials. The findings, presented at the AIDS Vaccine 2007 Conference in Seattle, suggest that many healthy southern and east Africans have, in the past, been excluded from participating in trials based on laboratory reference ranges that were developed for Western populations, and may not be appropriate locally.
   Similar news · Read more »
   
5. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
   07-19-2007 · EurekAlert!
   The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology, has yielded a new understanding of why some people can suppress virus levels following HIV infection. "The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers," says Elias A. Zerhouni, M.D., director of the National Institutes of Health.
   Similar news · Read more »
   
6. Genomic analysis uncovers new targets for HIV vaccine
   07-19-2007 · EurekAlert!
   An international team of researchers has identified three gene variants in the DNA of 486 people infected with HIV that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS.
   Similar news · Read more »
   
7. AIDS Avoidance: More studies find that circumcision deters HIV
   12-23-2006 · Science News Online
   Two large trials in Africa find that male circumcision limits HIV infection, which could prompt governments on that continent to promote or subsidize the operation.
   Similar news · Read more »
   
8. Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness
   12-25-2006 · EurekAlert!
   A team of researchers who conducted a landmark trial in Orange Farm, South Africa, which concluded that male circumcision can substantially reduce the risk of becoming infected with HIV, have now studied the economic aspects of this approach to preventing HIV/AIDS. Their new research, published in PLoS Medicine, suggests that circumcision could reduce the cost of health care in South Africa (and other sub-Saharan Countries), mainly through savings on the cost of HIV treatment.
   Similar news · Read more »
   
9. More aid required for chronic conditions in low income countries
   01-17-2007 · EurekAlert!
   Chronic conditions such as cardiovascular disease and cancer result in more deaths and account for more years of healthy life lost than most communicable diseases, and yet little international aid is focused on preventing or treating these conditions. Cardiovascular disease causes 30 percent of all deaths globally and 27 percent of deaths in low income countries. By comparison, HIV/AIDS, tuberculosis and malaria, combined, account for 10 percent of all deaths globally and 11 percent of death in developing countries.
   Similar news · Read more »
   
10. HIV isolate from Kenya provides clues for vaccine design
    01-02-2008 · EurekAlert!
    Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.
    Similar news · Read more »